For patient-related information about the ICT-107 cancer vaccine phase II program please:

  1. Access the ICT-107 FAQ (Frequently Asked Questions) click here.
  2. Send an email message to clintrials@imuc.com, including your contact information and your specific questions.
  3. Call 818 264 2315 and leave a brief message, including your contact information and questions.

Someone knowledgeable about the ICT-107 clinical program will respond to your inquiry shortly.

PRESS RELEASES

Thursday, March 19, 2015
ImmunoCellular Therapeutics Establishes Manufacturing Agreement with PharmaCell B.V. read more ...
Monday, March 09, 2015
ImmunoCellular Therapeutics Announces Financial Results and ICT-107 Update read more ...
Tuesday, March 03, 2015
ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th read more ...
Monday, March 02, 2015
ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Con read more ...

EVENTS

ImmunoCellular Therapeutics webcast at 27th Annual ROTH Conference
March 12 2015 Business Update Conference Call and Webcast
 
Copyright 2015 by Immunocellular Therapeutics, Ltd.
All Rights Reserved